Insufficient scRNA-seq data for expression of PGAP3 at single-cell level.
Insufficient scRNA-seq data for expression of PGAP3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 2030.01 | 328 / 328 | 100% | 64.85 | 178 / 178 |
thymus | 100% | 4513.98 | 653 / 653 | 100% | 90.78 | 605 / 605 |
uterus | 100% | 2001.26 | 170 / 170 | 100% | 56.65 | 458 / 459 |
prostate | 100% | 2726.16 | 245 / 245 | 99% | 60.99 | 499 / 502 |
brain | 99% | 1433.13 | 2615 / 2642 | 100% | 27.71 | 705 / 705 |
intestine | 100% | 2107.16 | 965 / 966 | 99% | 72.60 | 522 / 527 |
kidney | 100% | 2487.47 | 89 / 89 | 99% | 36.70 | 891 / 901 |
esophagus | 100% | 1877.56 | 1443 / 1445 | 99% | 81.68 | 181 / 183 |
breast | 100% | 2238.93 | 459 / 459 | 99% | 88.52 | 1104 / 1118 |
bladder | 100% | 1896.33 | 21 / 21 | 99% | 55.19 | 497 / 504 |
liver | 100% | 2094.21 | 225 / 226 | 99% | 41.58 | 402 / 406 |
lung | 100% | 1888.29 | 577 / 578 | 99% | 54.59 | 1139 / 1155 |
stomach | 100% | 1663.23 | 359 / 359 | 97% | 64.29 | 276 / 286 |
skin | 100% | 2563.68 | 1809 / 1809 | 96% | 24.39 | 453 / 472 |
ovary | 100% | 2020.88 | 180 / 180 | 95% | 29.06 | 410 / 430 |
adrenal gland | 100% | 1524.85 | 258 / 258 | 95% | 28.63 | 218 / 230 |
eye | 0% | 0 | 0 / 0 | 100% | 33.71 | 80 / 80 |
spleen | 100% | 1959.10 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 28.75 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 40.94 | 1 / 1 |
adipose | 100% | 1440.65 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1720.57 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 1120.55 | 845 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 20.47 | 28 / 29 |
muscle | 88% | 649.29 | 708 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 78% | 663.20 | 729 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006505 | Biological process | GPI anchor metabolic process |
GO_0006506 | Biological process | GPI anchor biosynthetic process |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005515 | Molecular function | protein binding |
GO_0016788 | Molecular function | hydrolase activity, acting on ester bonds |
Gene name | PGAP3 |
Protein name | Post-GPI attachment to proteins phospholipase 3 Post-GPI attachment to proteins factor 3 (COS16 homolog) (hCOS16) (Gene coamplified with ERBB2 protein) (PER1-like domain-containing protein 1) Post-GPI attachment to proteins factor 3 |
Synonyms | UNQ546/PRO1100 CAB2 PERLD1 |
Description | FUNCTION: Involved in the lipid remodeling steps of GPI-anchor maturation. Lipid remodeling steps consist in the generation of 2 saturated fatty chains at the sn-2 position of GPI-anchors proteins. Required for phospholipase A2 activity that removes an acyl-chain at the sn-2 position of GPI-anchors during the remodeling of GPI. . FUNCTION: Involved in the lipid remodeling steps of GPI-anchor maturation. . FUNCTION: Involved in the lipid remodeling steps of GPI-anchor maturation. . FUNCTION: Involved in the lipid remodeling steps of GPI-anchor maturation. . |
Accessions | J3KTJ2 J3QKU0 ENST00000619169.4 ENST00000429199.6 [Q96FM1-3] ENST00000378011.8 [Q96FM1-2] J3QRN7 ENST00000584856.1 ENST00000300658.9 [Q96FM1-1] ENST00000584620.5 ENST00000577337.5 Q96FM1 ENST00000579146.5 A0A087WTP0 J3QQL0 |